Kidney International

publication venue for

The caveolin-1 regulated protein follistatin protects against diabetic kidney disease. 96:1134-1149. 2019
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2019
The Authors Reply. 92:767-767. 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference. 92:297-305. 2017
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation. 91:928-936. 2017
Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. 91:683-690. 2017
Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis. 91:746-754. 2017
Plasmapheresis for the treatment of kidney diseases. 90:974-984. 2016
Application of new acute kidney injury biomarkers in human randomized controlled trials. 89:1372-1379. 2016
Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events. 89:1144-1152. 2016
Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee. 89:753-760. 2016
Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. 88:897-904. 2015
Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery. 88:576-583. 2015
Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. 87:784-791. 2015
Endothelin-1, but not angiotensin II, induces afferent arteriolar myosin diphosphorylation as a potential contributor to prolonged vasoconstriction. 87:370-381. 2015
A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection. 87:182-194. 2015
The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. 86:1205-1212. 2014
The three-year incidence of fracture in chronic kidney disease. 86:810-818. 2014
End-stage renal disease in living kidney donors. 86:20-22. 2014
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. 85:1303-1309. 2014
Biocompatible peritoneal dialysis solutions: many questions but few answers. 84:864-866. 2013
Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. 83:901-908. 2013
A multinational cohort study of in-center daily hemodialysis and patient survival. 83:300-307. 2013
Oral bisphosphonate use in the elderly is not associated with acute kidney injury. 82:903-908. 2012
Reporting of the estimated glomerular filtration rate decreased creatinine clearance testing. 81:1245-1247. 2012
Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD. 81:1248-1253. 2012
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 81:586-594. 2012
Vascular access surveillance: an ongoing controversy. 81:132-142. 2012
Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. 80:655-662. 2011
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. 79:1341-1352. 2011
Prevention and management of catheter-related infection in hemodialysis patients. 79:587-598. 2011
Traditional and non-traditional strategies to optimize catheter function: go with more flow. 78:1218-1231. 2010
The Authors Reply:. 78:112-112. 2010
Nephroprotective drugs from traditionally used Aboriginal medicinal plants. 77:471-472. 2010
Smad3-dependent and -independent pathways are involved in peritoneal membrane injury. 77:319-328. 2010
Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription. 76:1172-1179. 2009
Response to ‘The data on transplantation in Saudi Arabia are complex and require additional framework for interpretation’. 76:914-915. 2009
When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. 76:318-323. 2009
Global trends in the rates of living kidney donation. 75:1088-1098. 2009
Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. 75:542-549. 2009
Development of end stage renal disease following an acute cardiac event. 74:356-363. 2008
Plasma exchange for myeloma kidney: cast(s) away?. 73:1211-1213. 2008
Chronic kidney disease and postoperative mortality: A systematic review and meta-analysis. 73:1069-1081. 2008
Differences in tolerance for health risk to the living donor among potential donors, recipients, and transplant professionals. 73:1159-1166. 2008
Acute kidney injury: Better biomarkers and beyond. 73:801-803. 2008
Critical issues related to real-time fluorescence imaging of renal tissues using confocal microscopy. 73:656-656. 2008
Response to ‘Chronically decreased GFR and cardiovascular risk in living kidney donors’. 73:509-510. 2008
Studying channel and receptor physiology in podocytes. 73:364-364. 2008
Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex. 73:213-219. 2008
Improving on-line information for potential living kidney donors. 71:1062-1070. 2007
Response to ‘Reduced kidney function in living donors’. 71:1077-1077. 2007
When to refer patients with chronic kidney disease for vascular access surgery: Should age be a consideration?. 71:555-561. 2007
Frequent Hemodialysis Network (FHN) randomized trials: Study design. 71:349-359. 2007
Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase. 71:304-311. 2007
Lost in publication: Half of all renal practice evidence is published in non-renal journals. 70:1995-2005. 2006
Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. 70:1801-1810. 2006
Central venous catheter outcomes in nocturnal hemodialysis. 70:1348-1354. 2006
Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: A longitudinal pilot study. 70:956-962. 2006
Absence of renal sequelae after childhood Escherichia coli O157:H7 gastroenteritis. 70:807-812. 2006
Reply from the Authors. 68:2914-2914. 2005
Arteriovenous fistula outcomes in the era of the elderly dialysis population. 67:2462-2469. 2005
A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. 67:1500-1508. 2005
Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway. 67:1308-1314. 2005
Microalbuminuria three years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination. 67:1476-1482. 2005
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. 66:S59-S62. 2004
Activation of mesangial cell MAPK in responseto homocysteine. 66:733-745. 2004
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE Study. 65:1375-1380. 2004
Estimating the prevalence of renal insufficiency in seniors requiring long-term care. 65:649-653. 2004
Albuminuria and renal insufficiency prevalence guides population screening. 64:760-761. 2003
Albuminuria and renal insufficiency prevalence guides population screening. 64:761-762. 2003
Cardiovascular risk in patients with mild renal insufficiency. 63:S192-S196. 2003
Renal insufficiency and the risk of cardiovascular mortality. 62:1474-1474. 2002
Reply from the Authors. 62:1474-1475. 2002
Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. 61:2165-2175. 2002
Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. 61:1486-1494. 2002
Association between renal insufficiency and malnutrition in older adults: Results from the NHANES III. 60:1867-1874. 2001
Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: A prospective study. 58:2543-2545. 2000
Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout. 57:691-696. 2000
Stretch activation of Jun N-terminal kinase/stress-activated protein kinase in mesangial cells. 58:1431-1439. 2000
Nitric oxide modulates stretch activation of mitogen-activated protein kinases in mesangial cells. 58:1067-1077. 2000
Mesangial cell signaling cascades in response to mechanical strain and glucose. 56:1721-1728. 1999
Activation of mesangial cell signaling cascades in response to mechanical strain. 55:476-485. 1999
Dietary supplementation with L-arginine limits cell proliferation in the remnant glomerulus. 48:1857-1865. 1995
A controlled trial of cyclosporine in patients with progressive membranous nephropathy. 47:1130-1135. 1995
Fish oil in lupus nephritis: Clinical findings and methodological implications. 44:75-86. 1993
Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. 36:653-660. 1989
Prognosis of adult onset polycystic kidney disease re-evaluated. 26:190-193. 1984
Noninvasive monitoring of renal transplant function by analysis of beta2-microglobulin. 23:767-770. 1983
In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients. 23:506-513. 1983
In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients.. 23:506-513. 1983
Experimental nephritis associated with plasmodium infection in mice. 16:53-63. 1979
A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura 2009
Factors that led to the Walkerton tragedy 2009
Post-infectious irritable bowel syndrome following water contamination 2009
Relationship between Escherichia coli O157:H7 and diabetes mellitus 2009
Renal prognosis of toxigenic Escherichia coli infection 2009
Risk of pregnancy-related hypertension within five years of exposure to bacteria-contaminated drinking water 2009
TTP/HUS: observational studies generate hypotheses that lead to randomized controlled trials 2009
How much peritoneal dialysis is required for the maintenance of a good nutritional state? 1996
Flaxseed: A potential treatment for lupus nephritis 1995
MORBIDITY IN CHRONIC-HEMODIALYSIS PATIENTS - A STUDY OF PROGNOSIS 1990
THE PRESYMPTOMATIC DIAGNOSIS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD) 1990
THE PROGNOSIS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE - PKD-1 VS PKD2 1990
OMEGA-3 FATTY-ACID DIETARY SUPPLEMENTATION IN LUPUS NEPHRITIS 1989
RANDOMIZED CLINICAL-TRIAL (RCT) COMPARING PERITONITIS RATES AMONG NEW CAPD PATIENTS USING THE Y-SET DISINFECTANT SYSTEM (Y) TO STANDARD SYSTEMS (S) 1989
PERITONITIS IN CAPD PATIENTS-A RANDOMIZED CLINICAL-TRIAL (RCT) OF TRIMETHOPRIM-SULFAMETHOXAZOLE (TMP/SMX) PROPHYLAXIS 1988
REVERSAL OF PROTEINURIA AND REDUCTION OF MORTALITY IN NZB/W F1 LUPUS MICE BY PROSTAGLANDIN-E1 (PGE1), ILOPROST AND A THROMBOXANE SYNTHASE INHIBITOR (TSI) 1988
THE PRIMARY DETERMINANT OF ONE YEAR GRAFT-SURVIVAL OF CADAVER KIDNEY-TRANSPLANTS IS EARLY RENAL-FUNCTION 1988
PROSTAGLANDINS IN EXPERIMENTAL LUPUS NEPHRITIS 1987
REUSE OF DIALYZERS - A MULTIPLE CROSSOVER TRIAL WITH RANDOM ALLOCATION TO TREATMENT ORDER 1987
COMPLICATIONS RELATED TO THE ROUTE OF MINNESOTA ANTILYMPHOBLAST GLOBULIN (MALG) ADMINISTRATION IN RENAL-TRANSPLANT RECIPIENTS 1985
PRE-NATAL DIAGNOSIS OF KIDNEY DISORDERS BY ULTRASOUND 1985
SEQUENTIAL MINNESOTA ANTILYMPHOBLAST GLOBULIN (MALG) AND (CY) THERAPY AFTER CADAVER RENAL-TRANSPLANTATION 1985
ADULT POLYCYSTIC KIDNEY-DISEASE (APKD) - REAPPRAISAL OF PROGNOSIS 1984
CAPD IN TORONTO - THE 1ST 5 YEARS 1984
CAPD IN TORONTO - THE 1ST 5 YEARS 1984
CARPAL-TUNNEL SYNDROME IN DIALYSIS PATIENTS 1984
MONOCYTE PROCOAGULANT ACTIVITY (MPCA) AS A PREDICTOR OF RENAL PATHOLOGY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) 1984
MONOCYTE PROCOAGULANT ACTIVITY (MPCA) AS AN INDICATOR OF RENAL-ALLOGRAFT REJECTION 1984
CADAVERIC RENAL-TRANSPLANTS IN CHILDREN UNDER 6 YEARS OF AGE 1983
EFFECTIVENESS OF THIAZIDES IN PREVENTING RECURRENT CALCIUM UROLITHIASIS - THE QUALITY OF THE EVIDENCE 1983
BONE FLUORIDE IN RENAL OSTEODYSTROPHY 1982
KIDNEY-STONE ANALYSIS BY INFRARED-SPECTROSCOPY AS A PREDICTOR OF URINE CHEMISTRY 1981
POLYCYSTIC KIDNEY-DISEASE (PKD) AND GENETIC-MARKERS 1981
PLATELET-AGGREGATING IMMUNE-COMPLEXES IN IDIOPATHIC GLOMERULO-NEPHRITIS AND LUPUS NEPHRITIS 1980
UROLITHIASIS (U) - ENVIRONMENTAL AND GENETIC-FACTORS 1979
UROLITHIASIS (U) - ENVIRONMENTAL AND GENETIC FACTORS 1978
HYPERTENSION, HYPERRENINEMIA AND UNILATERAL RENAL-ARTERY OCCLUSION 1977

has subject area

1103 Clinical Sciences (FoR)
Urology & Nephrology (Science Metrix)

Kidney International Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)